Otonomy Appoints Chief Compliance Officer

By CW Staff2015-05-18T16:15:00

Otonomy, a clinical-stage bio-pharmaceutical company, has appointed Eric Loumeau as general counsel and chief compliance officer. Previously, Loumeau also served as general counsel and chief compliance officer for Hollis-Eden Pharmaceuticals, a publicly-traded biotechnology company. Details inside.

lock icon THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS

Already a Compliance Week member?

“For tracking litigation, enforcement, and regulatory developments, Compliance Weekshould be your prime source.”

Otonomy Appoints Chief Compliance Officer

Become a Member

“For tracking litigation, enforcement, and regulatory developments, Compliance Week
should be your prime source.”